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Abstract
Background: Proteomic analysis was performed to identify proteins regulated during infection by Dengue
serotypes 1 and 3 in an Aedes albopictus cell line. The potential of these viruses to cause severe disease at primary
infection is of interest although few studies have been performed with these two Dengue serotypes.
Results: The most relevant observation of our study is the significant overexpression of proteins involved in the
cellular stress response and the glycolysis pathway after 48 hours of infection. Viral infection activates the
translation of some host genes, which may result in stress due to responses involving unfolded proteins.
Conclusions: Therefore, the oxidation reduction and glycolytic mechanisms could participate in the antiviral
response against Dengue virus. The results of our study should help to improve our knowledge of the virus-mosquito
interaction at a cellular level with the aim of designing efficient strategies for the control of Dengue virus.
Background
Aedes aegypti (Diptera, Culicidae) is considered the
major vector for Dengue infection outbreaks worldwide
[1]. Aedes albopictus (Diptera, Culicidae) is a less effi-
cient vector for this virus, although it was involved in
Dengue outbreaks in Japan, Seychelles, Hawaii, and
Reunion Island [2]. The recent invasion of this second
vector into America, Europe, and Africa could increase
the transmission of arboviruses in tropical as well as
temperate regions [3,4]. Dengue virus (DENV) can cause
several clinical forms, ranging from an asymptomatic
disease to severe Dengue hemorrhagic fever (DHF) or
Dengue shock syndrome [5]. The World Health Organi-
zation estimates that 2.5 billion people live in more than
100 endemic areas where DENV can be transmitted [5].
DENV dramatically expands each year into new terri-
tories [6,7] as a consequence of combined factors such
as the rapid and easy mobility of human populations,
the distribution of mosquito vectors, and the lack of
herd immunity in unexposed populations [8].
There are four serotypes of DENV (DENV-1 to
DENV-4) that differ by their antigenic groups. Each
group can be divided into three to five different geno-
types. Therefore, it is difficult to take into consideration
all these factors when trying to determine the mechan-
isms involved in the pathogenesis of the virus. Many
researches have focused on DENV-2, which provokes
the most severe form of Dengue in secondary infection
[8,9], but types 1 and 3 have recently been found as new
emerged types in Europe and Africa [2,10]. The report
of two autochthonous DENV-1 infected persons in
metropolitan France in September 2010 is a recent
example of the introduction and local transmission of
DENV outside its traditional area [2]. Many studies have
reported that DENV-1 and DENV-3 cause severe disease
at primary infection while DENV-2 and DENV-4 are
frequently involved in Dengue outbreaks at secondary
infection [11-14].
Because there is no available antiviral treatment or vac-
cine to cure or prevent DENV, other approaches are
needed to fight and control the virus. A good under-
standing at the molecular level of the virus-mosquito
interaction should help with the design of efficient strate-
gies for the control of DENV. Mosquito cell infection is a
part of the Dengue viruses’ life cycle that is poorly under-
stood. In this study, we compared the proteome of
infected and non-infected cultures of the C6/36 Ae. albo-
pictus cell line using two-dimension a ld i f f e r e n t i a li n - g e l
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teins of infected mosquito cells. We chose DENV-1 and
DENV-3 as study models because of their remarkable
capacities to induce severe disease with the first infection.
Furthermore, travelers ha v em o r ec h a n c et od e v e l o p
DENV-1 or DENV-3 infection when they live in non-
endemic areas and have never been in contact with the
virus [2,10,15]. This could be due to the lack of herd
immunity in this human population [16].
Results
2-D-DIGE analysis of dengue infected and non-infected
C6/36 Ae. albopictus cells
C6/36 cells were collected 48 h after infection with DENV-
1, DENV-3, or a control (hereafter “mock infected”). We
chose to use 48 h post infection because it was previously
shown that this time corresponded to the exponential
phase for both DENV-1 and DENV-3 productions in C6/
36 cells [17]. We assumed that most cells are infected by
the virus at this time. Proteins were prepared and labelled
to run on 2D-DIGE. About 1500 spots were detected on
24 cm Immobiline DryStrip, pH 3-10 NL, followed by
SDS-PAGE electrophoresis (Figure 1). Our analysis of gel
images, quantification of protein expression, and statistical
analysis revealed 22 differentially expressed protein spots.
Notably, the mosquito cells infected by DENV-1 or
DENV-3 showed similar patterns of protein expression (i.e
same trend for the expression of proteome) compared to
mock infected cells. The protein expression patterns can
be divided into three groups according to the level of pro-
tein expression (Table 1). Group I includes 2 proteins that
are up-regulated in cells infected by DENV-1 compared
with their expression in DENV-3 infected and mock-
infected cells (Table 1). The second group is composed of
15 proteins, the expression of which is up-regulated in
DENV-3 infected cells compared to DENV-1 infected and
mock-infected cells (Table 1). In these two groups, the pro-
tein expression is higher in DENV-infected than in the
mock-infected cells (Table 1). The third group has 5 pro-
teins that are up-regulated in mock-infected cells com-
pared with the DENV-infected ones (Table 1).
Identification of candidate proteins
Twenty two spots were identified as being 13 different
proteins by Matrix assisted laser desorption ionisation
time-of-flight mass spectrometry (MALDI-TOF MS)
(Table 2). Several of these spots were identified as the
same protein. These different forms of a protein could be
due to post-translational modifications like glycosylation,
phosphorylation, acetylation, or protein degradation.
Nine of the 13 identified proteins belong to the groups 1
and 2, i.e., those proteins that are up-regulated in infected
conditions. Notably, five of these were enzymes involved
in the glycolysis pathway. These included enolase,
phosphoglycerate mutase, triosephosphate isomerase, fruc-
tose-bisphosphate aldolase, and glyceraldehyde-3-phos-
phate dehydrogenase (GAPD). The significant up-
regulation of these enzymes in virus-infected cells might
indicate that the virus disturbs glucose metabolism in host
cells [18]. The four remaining overexpressed proteins were
quinine oxidoreductase, chaperonin-60kD, and two puta-
tive uncharacterized proteins (Q17AU4_AEDAE and
BOWBF6_CULQU). Quinone oxidoreductase is impli-
cated in oxidation-reduction reactions; chaperonin-60kD
and Q17AU4_AEDAE are involved in protein folding pro-
cess; and BOWBF6_CULQU has no known function.
The four overexpressed proteins in mock-infected cells
were procollagen-lysine 2-oxyglutarate 5-dioxygenase
(PLOD), calponin, ethanolamine-phosphate cytidylyl-
transferase, and aconitase. PLOD is involved in the oxida-
tion-reduction necessary for the biosynthesis of collagen
[19]; calponin inhibits the ATPase activity of smooth
muscle myosin [20]; ethanolamine-phosphate cytidylyl-
transferase participates in biosynthesis specifically by
transferring phosphorus-containing nucleotide groups
[21]; and aconitase is a tricarboxylic acid cycle enzyme
that has a role in the regulation of iron metabolism [22].
Discussion
DENV usually induces apoptosis in infected mammalian
cells but causes less damage in mosquito cells [23]. The
mechanisms involved in the interaction between DENV
and insect cells have been described in recent studies
[9,24-27], but these only concern the DENV-2 virus sero-
type. DENV-1 and DENV-3 have been less studied than
DENV-2 and DENV-4. DENV-1 and DENV-3 have been
found to cause DHF at first infection [12]. This finding as
well as the recent report of DENV-1 introduction in
France [2] and the re-emergence of DENV-3 in Sudan
[28] attract our interest in these two virus serotypes. In
this study, we compared the proteomes of C6/36 Ae. albo-
pictus cells infected and non-infected with DENV-1 and
DENV-3.
Cells infected with DENV-1 and DENV-3 exhibited
many proteins that were differentially expressed compared
to the mock-infected cells. These data may reveal cellular
stress due to viral infection. In response to this stress,
mosquito cells utilize antioxidant reactions combined with
increased energy production to cope with the virus. The
up-regulation of chaperone proteins in infected cells
might be due to stress in the endoplasmic reticulum (ER)
induced by viral infection; ER is where proteins are synthe-
sized. Only proteins that are correctly folded by ER cha-
perones are transported to the Golgi apparatus. Misfolded
and unfolded proteins lead to ER stress. Eukaryotic cells
up-regulate ER chaperones and establish the cytoprotec-
tive mechanism known as the unfolded protein response
(UPR) to degrade the unfolded protein [29]. Molecular
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sized polypeptide chains and assembled subunits from
aggregating into nonfunctional structures [30]. Chaperone
proteins were shown to interfere with virus assembly and
replication in Ae. albopictus cells infected with Mayaro
virus, and thus protect the cells from injury during viral
infection [31]. Furthermore, the expression of Hsp90 was
required for the activity of hepatitis B virus reverse tran-
scriptase [32].
Interestingly, it has been reported that acute infection
of mammalian cells with several types of viruses often
results in the induction of heat-shock protein expression
[33]. The up-regulation of chaperone proteins 24 hours
after infection with DENV was previously reported [23].
These studies support our findings with infected cells,
which show two up-regulated proteins involved in pro-
tein folding biological process: chaperonin-60kD
(Q16PM9_AEDAE) and one putative uncharacterized
protein identified by mass spectrometry as being from
Culex quinequefasciatus (B0WBF6_CULQU). These
proteins belong to the heat-shock protein families
Hsp60 and Hsp70, respectively.
Cells require a chaperone function to prevent or cor-
rect misfolded or unfolded proteins created by environ-
mental stress. These chaperone proteins aid protein
folding in different ways. Hsp60 is a mitochondrial cha-
perone that generally assists the carrying and refolding
of proteins from the cytosol to mitochondria [34]. Many
Hsp70 chaperones could surround an unfolded substrate
to stabilize it and prevent aggregation until the unfolded
molecule folds properly, after which the Hsp70 chaper-
ones will lose affinity for the molecule and diffuse away
[34,35]. Hsp60 and Hsp70 could induce mitochondrial
UPR in the same way as the ER stress response [29].
The modulation of chaperone-associated proteins
could protect cells from apoptosis, as does the overex-
pression of calreticulin, which is a Ca
2+-binding chaper-
one protein [36]. These findings suggest that the
activation of these two chaperone proteins in infected
cells due to oxidative stress could induce UPR to cope
Figure 1 2D-DIGE synthetic gel of Ae. albopictus C6/36 cells infected or not with DENV-1 and DENV-3. Proteins were run with a pI scale
of 3-10. Protein spots differentially expressed (numbered spots) were identified by MALDI-TOF MS. The molecular weight scales are indicated in
the figure.
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increase of chaperone proteins may also be due to the
subversion of the cell by the virus in order to complete
viral replication. Indeed, it has been demonstrated that
flavivirus infection activates the key transcription factor
of the UPR and take advantage of this cellular response
to alleviate virus-induced cytotoxicity [37].
Chen et al. [23] further demonstrated that mosquito
cells use antioxidant mechanisms to survive DENV
infection. The changes in mitochondrial membrane
potential and the generation of superoxide confirm that
DENV induces oxidative stress in C6/36 cells [23]. This
supports our results showing the overexpression in
infected cells of quinone oxidoreductase, which is
increasingly recognized as the major contributor to reac-
tive oxygen species formation [38]. NADH quinone oxi-
doreductase catalyses NADH to NAD
+, reduces
ubiquinone, and transports protons across the inner
mitochondrial membrane. This enzyme complex also
reduces O2 to superoxide, which causes cellular oxida-
tive stress [38]. This means that mosquito cells use the
oxido-reduction mechanism to protect themselves
against DENV viral infection.
Another interesting result of our study is that five
enzymes involved in the glycolysis pathway were up-regu-
lated. Increased glucose uptake and glycolytic enzyme
activity due to viral infection have been found in other stu-
dies [39,40]. The induction of glycolytic proteins involved
in energy production is also found in CHIKV and DENV-
2i n f e c t i o n s[ 9 ] .R i t t e re ta l .[ 1 8 ]s u g g e s t e dt h a tt h e
increased activity of glycolysis was due to the breakdown
of the mitochondrial membrane, which decreased ATP
concentration. As a result, the glycolysis pathway was acti-
vated to compensate for the lack of energy [18]. Recent
studies have demonstrated more multifaceted functions of
glycolytic enzymes such as GAPD and enolase. Both of
these acquired non-glycolytic functions in transcriptional
regulation. Moreover, GAPD might play a role as regulator
or indicator of apoptosis [41]. Glycolysis is also reported to
be the main source of energy production in Trypanosoma;
this finding could represent a new drug target against
parasites [42,43]. In addition, it has been reported that
Table 1 Differential protein expression between an uninfected and DENV-infected C6/36 Ae.albopictus cell line
Spot N° ANOVA (p) Fold Average Normalized Volumes Functional annotation
DENV 1 DENV 3 CONTROL C6-36
Group I: DV1>DV3>C
978 8.98E-13 2.6 1.594 1.53 0.605 Putative uncharacterized protein
663 2.88E-09 2.6 1.604 1.183 0.613 Quinone oxidoreductase
Group II: DV3>DV1>C
838 9.00E-11 4.3 1.114 1.79 0.421 Enolase
849 5.34
E -13 3.3 1.395 1.947 0.584 Enolase
606 3.16E-07 3.2 1.111 1.323 0.417 Putative uncharacterized protein
1153 6.09E-10 2.9 1.235 1.584 0.549 Phosphoglycerate mutase
608 3.21E-07 2.8 1.305 1.429 0.507 Putative uncharacterized protein
1181 1.50E-10 2.7 1.18 1.559 0.57 Triosephosphate isomerase
935 5.15E-10 2.7 1.251 1.569 0.579 Fructose-bisphosphate aldolase
1150 5.47E-11 2.5 1.237 1.551 0.608 Phosphoglycerate mutase
605 2.57E-06 2.3 0.898 1.094 0.483 Putative uncharacterized protein
716 3.46E-05 2.3 0.962 1.148 0.489 Chaperonin-60kD
1182 1.52E-13 2.2 1.32 1.541 0.703 Triosephosphate isomerase
938 1.39E-11 2.2 1.214 1.477 0.684 Fructose-bisphosphate aldolase
951 3.83E-11 2.2 1.113 1.454 0.67 Fructose-bisphosphate aldolase
1017 3.84E-10 2.1 1.002 1.367 0.653 Glyceraldehyde-3-phosphate dehydrogenase
1011 4.09E-08 2.1 0.951 1.313 0.612 Glyceraldehyde-3-phosphate dehydrogenase
Group III: C>DV1 and DV3
1255 1.65E-12 2.0 0.814 0.758 1.509 Calponin
529 1.51E-10 3.1 0.49 0.605 1.511 Procollagen-lysine,2-oxoglutarate 5-dioxygenase
528 2.32E-13 2.8 0.476 0.618 1.326 Procollagen-lysine,2-oxoglutarate 5-dioxygenase
867 2.69E-10 2.0 0.672 0.74 1.328 Ethanolamine-phosphate cytidylyltransferase
442 9.77E-08 2.0 0.763 0.834 1.500 Aconitase
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N°
spot
DIGE
Entree
Swissprot_TrEMBL
Identification Biological
process
Cellular
component
Molecular function Sequence
similarities
Pathway Molecular
mass (Da)
pI MASCOT
score
Cover
sequence
Protein up-regulated in infected cells
978* Q17AU4_AEDAE Putative
uncharacterized
protein
42429 6.5 82 25
663* Q16S95_AEDAE Quinone
oxidoreductase
Oxidation
reduction
Oxidoreductase activity, zinc
ion binding
50810 5.6 121 31
838°,
849°
Q17KK5_AEDAE Enolase Glycolysis Cell surface,
phosphopyru-
vate
hydratase
complex
Magnesium ion binding,
phosphopyruvate hydratase
activity
Belongs to the
enolase family.
Carbohydrate
degradation, glycolysis,
pyruvate from D-
glyceraldehyde 3-
phosphate: step 4/5
46877 6.3 202 53
605°,
606°,
608°
B0WBF6_CULQU Putative
uncharacterized
protein
Protein
folding
Chaperone, ATP binding,
unfolded protein binding
Belongs to the
heat shock
protein 70
family
72845 5.9 188 32
1150°,
1153°
Q177P3_AEDAE Phosphoglycerate
mutase
Glycolysis 2,3-bisphosphoglycerate-
dependent phosphoglycerate
mutase activity
28582 6.6 131 41
1181°,
1182°
Q17HW3_AEDAE Triosephosphate
isomerase
Glycolysis Isomerase, triose-phosphate
isomerase activity
Belongs to the
triosephosphate
isomerase family
Carbohydrate
biosynthesis,
gluconeogenesis,
carbohydrate
degradation, glycolysis,
D-glyceraldehyde 3-
phosphate from
glycerone phosphate:
step 1/1
26705 6 161 44
935°,
938°,
951°
Q178U8_AEDAE Fructose-
bisphosphate
aldolase
Glycolysis Fructose-bisphosphate aldolase
activity
Belongs to the
class I fructose-
bisphosphate
aldolase family.
Carbohydrate
degradation, glycolysis,
D-glyceraldehyde 3-
phosphate and
glycerone phosphate
from D-glucose: step 4/
4
39551 8 172 50
716° Q16PM9_AEDAE Chaperonin-60kD Protein
refolding
Cytoplasm ATP binding, unfolded protein
binding, chaperone
Belongs to the
chaperonin
(Hsp60) family
61155 5.5 75 20
1011°,
1017°
B0WEB5_CULQU Glyceraldehyde-3-
phosphate
dehydrogenase
Glycolysis,
oxidation
reduction
Cytoplasm NAD or NADH binding,
glyceraldehyde-3-phosphate
dehydrogenase
(phosphorylating) activity
Belongs to the
glyceraldehyde-
3-phosphate
dehydrogenase
family
Carbohydrate
degradation, glycolysis,
pyruvate from D-
glyceraldehyde 3-
phosphate: step 1/5
35693 8.5 114 40
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9Table 2 Protein identification by MALDI-TOF MS (Continued)
Protein up-regulated in non-infected cells
1255
# Q1HR19_AEDAE Calponin 20936 8.3 183 73
528
#,
529
#
Q0IER9_AEDAE Procollagen-
lysine,2-
oxoglutarate 5-
dioxygenase
Oxidation
reduction
L-ascorbic acid binding, iron
ion binding, oxidoreductase
activity acting on paired
donors with incorporation or
reduction of molecular oxygen,
oxidoreductase activity acting
on single donors with
incorporation of molecular
oxygen, incorporation of two
atoms of oxygen
82324 5.7 202 25
867
# Q179F9_AEDAE Ethanolamine-
phosphate
cytidylyltransferase
Biosynthetic
process
Nucleotidyltransferase activity 42278 6.1 102 23
442
# Q16ZG5_AEDAE Aconitase Metabolic
process
4 iron, 4 sulfur cluster binding 99252 5.8 165 23
Symbol : * represents proteins that are up-regulated in cells infected by DENV-1, ° represents proteins that are up-regulated in cells infected by DENV-3 and
# represents proteins that are up-regulated in mock-
infected cells.
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9GAPDH binds to the minus-strand RNAs of Japanese
encephalitis virus and the subcellular localization of
GAPDH changed upon JEV infection, suggesting that
GAPDH may play a role during the virus life cycle [44].
These evidences suggest that blocking the glycolysis path-
way could constitute a new tool in the fight against mos-
quito-borne diseases via their vector control. The increase
in glycolytic enzymes could also be a result of the arrest at
the G1 cell cycle due to UPR.
Conclusions
The modulation of protein expression found in our study
might be the strategy of the virus to overcome host path-
ways to facilitate survival at the expense of the host.
Further studies are needed to understand the mechanism
by which these proteins are induced during viral infection.
Virus could stimulate the transcription and translation of
some host products for their survival, but the mechanism
is still unknown. The modulation of protein expression
could also be the mosquito’s response to the viral infec-
t i o n .I tw o u l db ei n t e r e s t i n gi naf u r t h e rs t u d y ,t od e t e r -
mine whether a similar response occurs in cells infected
with another virus or if the observed modulation of pro-
tein expression is specifically induce in response to DENV
infection. Mosquitoes generate oxido-reduction stress to
cope with the virus and stimulate the glycolysis pathway
to prevent cellular damage. Thus, it might be beneficial to
understand the proteome of infected cells to develop an
anti-pathogen approach. However, these proteomics stu-
dies need to be complemented by studies using RNAi
gene silencing to allow the characterization of modulated
genes in vivo in mosquito tissues. Improvements in our
knowledge on mosquito cell systems will be important to
decipher the infection process of dengue virus in human.
Methods
Cell culture and virus infection
Ae. Albopictus C6/36 cells were grown in minimal essen-
tial medium supplemented with 10% fetal calf serum, 1%
L-glutamine, 1% sodium bicarbonate, 1% nonessential
amino acids, 50 U/mL of penicillin, and 50 μg/mL of
streptomycin at 28°C [45]. Cells were infected with two
serotypes of Dengue virus, DENV-1 (Hawaii strain) and
DENV-3 (H87 strain), at an multiplicity of infection of
0.01 then incubated at 28°C for 48 hours [17]. Mock-
infected cells were used as the normal physiological con-
trol and represent cells incubated with supernatant of
uninfected C6/36. The experiment was done in quadrupli-
cate. The DENV-1 and DENV-3 virus stocks were propa-
gated in C6/36 Ae. albopictus cells.
Protein sample preparation
Infected or mock-infected cells were washed with PBS
and then lysed by solubilizing buffer (7 M urea, 2 M
thiourea, 4% CHAPS, 0.5% Triton X-100, and 40 mM
Tris-HCl). After a centrifugation at 16000 × g for 45
min, the supernatants were collected and protein con-
centrations were measured using a 2-D Quant kit (GE
Healthcare).
2D-DIGE, image scanning, and statistical analysis
For analytical 2D-DIGE, DENV-1 and DENV-3 infected
and non-infected protein samples were compared using
the CyDye DIGE Fluors for Ettan DIGE (Cy2, Cy3, and
Cy5). Proteins were labelled according to the Ettan DIGE
minimal labelling protocol (Ettan DIGE User Manual, GE
Healthcare). For each sample (DENV-1, DENV-3 or
mock-infected protein samples), 50 μgo fp r o t e i nw a s
labeled with 400 pmol of either Cy3 or Cy5. The internal
standard was a pool of equal amounts (25 μg) from all
samples which was labeled with Cy2. These labeled sam-
ples were then combined and loaded on gels. Every gels
contained 50 μg of sample labeled with Cy3, 50 μgo f
sample labeled with Cy5 and 50 μg of internal standard
labeled with Cy2. The sample volume was made up to
450 μL by adding rehydration buffer (7 M urea, 2 M
thiourea, 4% CHAPS, 0.5% Triton X-100, 40 mM Tris-
HCl, 1% IPG buffer, and 1.2% DeStreak) prior to separa-
tion by isoelectric focusing (IEF). IEF was performed with
24 cm Immobiline DryStrip, pH 3-10 NL. The run condi-
tions were as follows: rehydration for 14 h at 20°C, cur-
rent of 50 μA per strip, 60 V (step) for 3 h, 1000 V
(gradient) for 4 h, 8000 V (gradient) for 4 h, and 8000 V
(step) until reaching a total of 64 000 Vh. 2-DE was per-
formed on 12% SDS-PAGE gel at 15 mA/gel for 6 h and
then at 30 mA/gel until the bromophenol blue front
reached the end of the gel. Gels were scanned using a
Typhoon 9400 imager (Amersham Biosciences). All gel
images were acquired at 100 μm pixel resolution under
nonsaturating conditions. 2D-DIGE images were ana-
lyzed using Progenesis SameSpots 3.1 software. Statistical
analysis and protein quantification were carried out using
this software with ANOVA which took into account the
mean difference and the variance among 3 groups:
DENV-1, DENV-3 and mock-infected groups. The fold
change with a cut-off of 2.0-fold up- or down-regulated
was used (calculated between the lowest mean normal-
ised volume and the highest mean normalised volume of
each spot). The statistical power of this study was greater
than 0.8. Protein spots with a significant altered expres-
sion (p < 0.001) were trypsin digested and identified with
mass spectrometry.
Protein identification by MALDI-TOF MS
For 2D-DIGE, gels were run with 150 μgo fam i xo f
protein from the different samples (50 μg of each sam-
ple labeled with Cy3, Cy5 and Cy2) and these gels were
afterwards stained with CBB. Spots of interest were
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pattern with the 2D-DIGE protein pattern. To ensure
consistency, gels were analysed using Progenesis Same-
Spots 3.1 software and differential spots were identified.
Gel image containing differential spots and picking gels
were compared physically side-by-side and the candidate
spots were excised manually in a laminar flow hood.
Enzymatic in-gel digestion through peptide spotting and
protein identification was performed as previously
described [46,47]. Briefly, protein spots were digested
using 150 ng of trypsin, peptide extraction was per-
formed using five sonication cycles of 2 min each, and
peptides were concentrated 1 h at 50°C; 0.5 μLo fs a m -
ple peptide and 0.5 μL of CHCA were deposited on a
384-well MALDI anchorship target using the dry-dro-
plet procedure. Peptide samples were then desalted on
the target using a 10 mM phosphate buffer. Analyses
were performed using an UltraFlex I MALDI TOF-TOF
mass spectrometer (Bruker Daltonics, Bremen, Ger-
many) in the reflectron mode with a 26 kV accelerating
voltage and a 50 ns delayed extraction. Mass spectra
were acquired manually or in the automatic mode using
the AutoXecute module of Flexcontrol (Bruker Dal-
tonics) (laser power ranged from 30 to 50%, 600 shots).
Spectra were analyzed using FlexAnalysis software (Bru-
ker Daltonics) and calibrated internally with the autop-
roteolysis peptides of trypsin (m/z 842.51, 1045.56,
2211.10). Peptides were selected in the mass range of
900-3000 Da. Peptide Mass Fingerprint identification of
proteins was performed by searching against the Insecta
entries of either the Swiss-Prot or TrEMBL databases
http://www.expasy.ch and by using the MASCOT v 2.2
algorithm (http://www.matrixscience.com) with trypsin
enzyme specificity and one trypsin missed cleavage
allowed [48]. Carbamidomethyl was set as fixed cystein
modification and oxidation was set as variable methio-
nine modification for searches. A mass tolerance of 50
ppm was allowed for identification. Matching peptides
with one missed cleavage were considered as pertinent
when there were two consecutive basic residues or
when arginine and lysine residues were in an acidic con-
text. MASCOT scores higher than 65 were considered
as significant (p < 0.05) for Swiss-Prot and TrEMBL
database interrogations.
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